Table 1.

Baseline characteristics of study population.

Characteristic		Control group, (n=176), n (%)	Intervention group, (n=176), n (%)	P
Age, mean (SD)		49.3 (11.0)	52.4 (11.0)	.008
Female		148 (84.1)	141 (80.1)	.33
Race				.84
	Caucasian	150 (85.2)	157 (89.2)
	Asian	9 (5.1)	8 (4.6)
	African American	4 (2.3)	2 (1.1)
	American Indian/Alaskan Native	3 (1.7)	2 (1.1)
	Native Hawaiian/Pacific Islander	3 (1.7)	1 (0.6)
	Other	7 (4.0)	6 (3.4)
Married		122 (69.3)	109 (61.9)	.14
Highest year education attained, mean (SD)		16.5 (3.1)	16.3 (2.8)	.62
Smoking status				.43
	Current	4 (2.3)	7 (4.0)
	Former	57 (32.4)	64 (36.4)
	Never	115 (65.3)	105 (59.7)
Type of cancer diagnosed a				.70
	Breast	84 (47.7)	83 (47.2)
	Endometrium/Uterine/Ovarian	23 (13.1)	22 (12.5)
	Non-Hodgkins Lymphoma	13 (7.4)	7 (4.0)
	Colorectal	11 (6.5)	11 (6.5)
	Lung	7 (4.0)	8 (4.6)
	Thyroid	6 (3.4)	8 (4.6)
	Oral	6 (3.4)	5 (2.8)
Stage of cancer				.96
	In situ	9 (5.1)	7 (4.0)
	Stage 1	45 (25.6)	45 (25.6)
	Stage 2	52 (29.6)	55 (31.3)
	Stage 3	37 (21.0)	41 (23.3)
	Stage 4	16 (9.1)	13 (7.4)
	Unknown	17 (9.7)	15 (8.5)
Number of years since cancer diagnosed, mean (SD)		2.5 (1.3)	2.4 (1.4)	.41
Number of years since treatment completed, mean (SD)		1.9 (1.2)	1.7 (1.2)	.09
Prevalence of long-term health conditions
	High blood pressure	31 (17.6)	34 (19.3)	.68
	Depression	32 (18.2)	29 (16.5)	.67
	Back pain	25 (14.2)	29 (16.5)	.55
	Anxiety	29 (16.5)	23 (13.1)	.37
	Arthritis	18 (10.2)	27 (15.3)	.15
	Sleep disorder	18 (10.2)	12 (6.8)	.25
	Asthma	13 (7.4)	13 (7.4)	1.0
	Diabetes	9 (5.1)	11 (6.3)	.65
	Heart disease	3 (1.7)	8 (4.6)	.13
	Emphysema, COPD, chronic bronchitis	3 (1.7)	5 (2.8)	.72
	Other	39 (22.2)	39 (22.2)	1.0

^aSites also reported were oral cavity (n=11), soft tissue (n=11), testicular (n=10), kidney and renal (n=10), and other [n=26, including brain (n=5), prostate (n=4), eye (n=3)].